Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia

Authors :: Tsuyoshi, Okada
Hikaru, Hori
Naomi, Hasegawa
Atsunobu, Murata
Yoshitaka, Kyou
Fumitoshi, Kodaka
Hitoshi, Iida
Shinichiro, Ochi
Yoshikazu, Takaesu
Takashi, Tsuboi
Jun-Ichi, Iga
Kayo, Ichihashi
Hiroyuki, Muraoka
Ryuji, Furihata
Norio, Yasui-Furukori
Masahide, Usami
Toshiaki, Onitsuka
Kazuyoshi, Ogasawara
Hiromi, Tagata
Masahiro, Takeshima
Kazutaka, Ohi
Shusuke, Numata
Naoki, Hashimoto
Hiroki, Yamada
Manabu, Makinodan
Hiroshi, Komatsu
Akitoyo, Hishimoto
Hirotaka, Yamagata
Mikio, Kido
Chika, Kubota
Kiyokazu, Atake
Hisashi, Yamada
Tatsuya, Nagasawa
Junya, Matsumoto
Kenichiro, Miura
Ken, Inada
Koichiro, Watanabe
Shiro, Suda
Ryota, Hashimoto
Source :: Journal of Clinical Psychopharmacology. 42:591-593
Publication Year :: 2022
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2022.

Subjects :: Psychiatry and Mental health
Schizophrenia
Humans
Pharmacology (medical)
Cholinergic Antagonists
Antipsychotic Agents

Full Text Access

Tools